![Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer | Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer | The National Academies Press Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer | Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer | The National Academies Press](https://nap.nationalacademies.org/books/0309086108/gifmid/19.gif)
Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer | Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer | The National Academies Press
![Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial - The Lancet Child & Adolescent Health Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial - The Lancet Child & Adolescent Health](https://www.thelancet.com/cms/attachment/e248c192-6e99-4634-aa5e-6ec86c0f9eb9/gr1_lrg.jpg)
Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial - The Lancet Child & Adolescent Health
![2016 Breast Cancer Highlight - Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer , Breast Cancer Research Program, Congressionally Directed Medical Research Programs 2016 Breast Cancer Highlight - Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer , Breast Cancer Research Program, Congressionally Directed Medical Research Programs](https://cdmrp.health.mil/images/misc/nair_figure.jpg)
2016 Breast Cancer Highlight - Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer , Breast Cancer Research Program, Congressionally Directed Medical Research Programs
![Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains | Fierce Biotech Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1530129963/TSC_Benson_Exterior_Night_1.jpg?VersionId=aqX9zTL1rQzf9lUYiCJNdHuoRpYKS_.j)
Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains | Fierce Biotech
![Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma | npj Genomic Medicine Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma | npj Genomic Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41525-020-0130-7/MediaObjects/41525_2020_130_Fig1_HTML.png)
Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma | npj Genomic Medicine
![Vaccines | Free Full-Text | Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms Vaccines | Free Full-Text | Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms](https://www.mdpi.com/vaccines/vaccines-10-01448/article_deploy/html/images/vaccines-10-01448-g001-550.jpg)
Vaccines | Free Full-Text | Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms
![Duke Study: Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21% | Duke Department of Neurosurgery Duke Study: Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21% | Duke Department of Neurosurgery](https://neurosurgery.duke.edu/sites/default/files/2021-08/gromeier-poliovirus-500x283.jpg)